The Market Rush and Recovery in the Pharmaceutical Industry

Linda discusses the ups and downs of the pharmaceutical market, covering the impact of unforeseen variables like the COVID pandemic and geopolitical conflicts. She also highlights the current recovery phase with a rise in partnering and large deals, amounting to almost $20 billion in the last six months.